Correction: Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Vavolizza RD, Petroni GR, Mauldin IS, et al. Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64). J Immunother Cancer 2022;10:e005424. doi: 10.1136/jitc-2022-005424

The author Rick Daniel Vavolizza has been updated to Rick D Vavolizza.